The cannabinoid CB1receptor and the endocannabinoid anandamide: possible antidepressant targets

The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet

(2008) V Di Marzo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review

(2008) Claire Daban et al.   JOURNAL OF AFFECTIVE DISORDERS

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1knockout mice

(2008) Ester Aso et al.   JOURNAL OF NEUROCHEMISTRY

Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report

(2008) M. Hill et al.   PHARMACOPSYCHIATRY

Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects

(2008) Emmanuel S. Onaivi et al.   PLoS One

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

(2008) Irving Kirsch et al.   PLOS MEDICINE

Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus

(2007) Matthew N. Hill et al.   HIPPOCAMPUS

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice

(2007) Michel A. Steiner et al.   PSYCHONEUROENDOCRINOLOGY